Market Size – USD 8.47 billion in 2019, Market Growth - CAGR of 9.4 %, Market Trends – Rapid advancement in technology.

New York, NY -- (SBWire) -- 04/20/2021 --The increase in awareness regarding chronic diseases and availability of nanoemulsion treatments is driving the growth of the market.

Market Size – USD 8.47 billion in 2019, Market Growth - CAGR of 9.4 %, Market Trends – Rapid advancement in technology.

The global Nanoemulsions Market is forecast to reach USD 17.50 billion in 2027, according to a new report by Reports and Data. Nanoemulsions are another novel drug delivery forms. They are widely used in various application such as DNA encoded drug, vaccine delivery, cosmetic & topical preparations, and antibiotics. The primary benefit of nanoemulsions is that they eliminate an inconsistency in absorption, and enhance the absorption rate, increases bioavailability, assists in the solubility of lyophilic drugs and provides high thermodynamic stability.

Nanoemulsions are being used to enhance the solubility and bioavailability of drugs insoluble in water. The drug has gained traction due to its delivery for hydrophilic as well as hydrophobic drug owing to its improved drug solubilization capacity, ease of preparation, longer shelf life, and improvement of bioavailability of drugs.The benefits provided by the market has attracted great attention in research, dosage design, and pharmacotherapy. These type of drugs are designed to address problems associated with traditional drug delivery systems such as noncompliance and low bioavailability.

Key participants include Allergen plc, Covaris, Inc., Ascendia Pharmaceuticals, Foamix Pharmaceuticals, Taiwan Liposome Company, Ltd., Santen Pharmaceuticals Co., Ltd., Mitsubishi Tanabe Pharma, Microfluidics (IDEX Corporation), Latitude Pharmaceuticals Inc., and AstraZeneca plc among others.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1559

Further key findings from the report suggest

- Antibiotics dominated the segment of applications of nanoemulsions. It held the market share of ~29% in the year 2018. Increasing attention of nanoemulsions in antibiotics is boosting the growth of the market. The rise in demand for antibiotics is also generating a demand for the market in the segment.
- Nanoemulsions are increasingly finding great application in Nonsteroidal anti-inflammatory drugs (NSAIDs) and Immunosuppressants. They each have a forecasted CAGR of 5.3% and 5.1% during the forecast period.
- An increasing number of biopharmaceutical companies are showing interest in the application of nanoemulsions in vaccines. Research and tests have shown positive results for the usage of the market product in vaccines. These vaccines are being developed for the treatment of chronic infections and cancer diseases through targeted therapies.
- A nanoemulsion drug delivery system was developed to increase the oral bioavailability of drugs with a very low profile. Nanoemulsion drugs are minute in size, and consuming them orally is a little difficult. They are generally used topically or intravenously. Injecting it in the body is a quick and easy way of delivering the drug. It held the largest market share of ~33% in the year 2018.
- Asia Pacific is forecasted to have the highest growth rate of 10.7% during the forecast period. Change in demographics and growing disposable income is driving the market, especially in densely populated areas such as India and China.

To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/nanoemulsions-market

For the purpose of this report, Reports and Data have segmented into the global nanoemulsions market on the basis of applications, route of administration, distribution channel, and region:

Applications Outlook (Volume, Kilo Tons; Revenue, USD Billion; 2017-2027)

Anesthetics
Antibiotics
Nonsteroidal anti-inflammatory drugs (NSAIDs)
Immunosuppressants
Steroids
Others

Route of Administration Outlook (Volume, Kilo Tons; Revenue, USD Billion; 2017-2027)

Oral
Topical
Intravenous
Others

Distribution Channel Outlook (Volume, Kilo Tons; Revenue, USD Billion; 2017-2027)

Hospital Chain
Retail Stores
Others

Regional Outlook (Volume, Kilo Tons; Revenue, USD Billion; 2017-2027)

North America
Europe
Asia Pacific
MEA
Latin America

Request for Customization: @ https://www.reportsanddata.com/request-customization-form/1559

Table of Content:

Chapter 1. Market Synopsis
    1.1. Market Definition
    1.2. Research Scope & Premise
    1.3. Methodology
    1.4. Market Estimation Technique
Chapter 2. Executive Summary
    2.1. Summary Snapshot, 2018-2026
Chapter 3. Indicative Metrics
Chapter 4. Nanoemulsions Market Segmentation & Impact Analysis
    4.1. Nanoemulsions Market Material Segmentation Analysis
    4.2. Industrial Outlook
         4.2.1. Market indicators analysis
         4.2.2. Market drivers analysis
                 4.2.2.1. Rise in chronic diseases
                 4.2.2.2. Increasing awareness regarding nanoemulsions treatment
                 4.2.2.3. Rise in government initiative towards target specific drugs
         4.2.3. Market restraints analysis
                 4.2.3.1. High cost of manufacturing
    4.3. Technological Insights
    4.4. Regulatory Framework
    4.5. ETOP Analysis
    4.6. Porter's Five Forces Analysis
    4.7. Competitive Metric Space Analysis
    4.8. Price trend Analysis
….
Chapter 9. Competitive Landscape
    9.1. Market Revenue Share By Manufacturers
    9.2. Manufacturing Cost Breakdown Analysis
    9.3. Mergers & Acquisitions
    9.4. Market positioning
    9.5. Strategy Benchmarking
    9.6. Vendor Landscape
Chapter 10. Company Profiles
    10.1. Allergen plc
           10.1.1. Company Overview
           10.1.2. Financial Performance
           10.1.3. Technology Insights
           10.1.4. Strategic Initiatives
    10.2. Covaris, Inc.
           10.2.1. Company Overview
           10.2.2. Financial Performance
           10.2.3. Technology Insights
           10.2.4. Strategic Initiatives
    10.3. Ascendia Pharmaceuticals
           10.3.1. Company Overview
           10.3.2. Financial Performance
           10.3.3. Technology Insights
           10.3.4. Strategic Initiatives
    10.4. Foamix Pharmaceuticals
           10.4.1. Company Overview
           10.4.2. Financial Performance
           10.4.3. Technology Insights
           10.4.4. Strategic Initiatives
    10.5. Taiwan Liposome Company, Ltd.
           10.5.1. Company Overview
           10.5.2. Financial Performance
           10.5.3. Technology Insights
           10.5.4. Strategic Initiatives

Continue….

Thank you for reading our report. For customization inquiry or further information, please connect with us and we will ensure you get the report that meets your requirements. 

About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com